Someone with a lot of money to spend has taken a bullish stance on TG Therapeutics TGTX.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with TGTX, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for TG Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $461,046, and 9, calls, for a total amount of $343,079..
Latest Startup Investment Opportunities:
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $40.0 for TG Therapeutics over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for TG Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of TG Therapeutics's whale trades within a strike price range from $25.0 to $40.0 in the last 30 days.
TG Therapeutics Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| TGTX | PUT | SWEEP | BULLISH | 01/19/24 | $40.00 | $461.0K | 158 | 0 |
| TGTX | CALL | SWEEP | BULLISH | 01/19/24 | $35.00 | $78.4K | 2.5K | 3 |
| TGTX | CALL | SWEEP | BULLISH | 05/19/23 | $29.00 | $48.0K | 102 | 150 |
| TGTX | CALL | SWEEP | BULLISH | 01/19/24 | $30.00 | $37.6K | 2.0K | 38 |
| TGTX | CALL | SWEEP | BEARISH | 05/19/23 | $25.00 | $33.2K | 7.6K | 52 |
Where Is TG Therapeutics Standing Right Now?
- With a volume of 3,023,336, the price of TGTX is down -5.83% at $31.75.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 87 days.
What The Experts Say On TG Therapeutics:
- HC Wainwright & Co. downgraded its action to Buy with a price target of $34
- HC Wainwright & Co. downgraded its action to Buy with a price target of $28
- Cantor Fitzgerald downgraded its action to Overweight with a price target of $24
- Ladenburg Thalmann has decided to maintain their Buy rating on TG Therapeutics, which currently sits at a price target of $37.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for TG Therapeutics, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
